论文部分内容阅读
目的分析依达拉奉治疗急性脑梗死的临床疗效。方法 80例急性脑梗死患者,随机分为观察组与对照组,各40例。观察组患者接受依达拉奉治疗,对照组患者接受胞二磷胆碱治疗,观察两组患者的临床治疗效果。结果经治疗后,观察组患者显效23例,有效13例,无效4例,总有效率为90.0%,对照组患者显效18例,有效14例,无效8例,总有效率为80.0%,比较差异有统计学意义(P<0.05)。结论急性脑梗死患者接受依达拉奉治疗后可有效改善神经功能缺损,促进患者神经修复,可在临床中推广。
Objective To analyze the clinical efficacy of edaravone in the treatment of acute cerebral infarction. Methods Eighty patients with acute cerebral infarction were randomly divided into observation group and control group, 40 cases in each. Patients in the observation group received edaravone treatment, patients in the control group received citicoline treatment, and the clinical effects of the two groups were observed. Results After treatment, the effective rate of the observation group was 23, the effective rate was 13, the total effective rate was 90.0%. The control group was markedly effective in 18 cases, effective in 14 cases and ineffective in 8 cases, the total effective rate was 80.0%. The difference was statistically significant (P <0.05). Conclusion The treatment of edaravone in patients with acute cerebral infarction can effectively improve the neurological deficits and promote the nerve repair in patients, which can be promoted in clinic.